|
|
|
Volumn 106, Issue , 2005, Pages 85-111
|
|
Clinical studies of antisense oligonucleotides for cancer therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTISENSE OLIGONUCLEOTIDE;
CYCLIC AMP DEPENDENT PROTEIN KINASE;
DNA METHYLTRANSFERASE;
PRKCA PROTEIN, HUMAN;
PROTEIN BCL 2;
PROTEIN C MYB;
PROTEIN KINASE C;
PROTEIN KINASE C ALPHA;
RAF PROTEIN;
RIBONUCLEOTIDE REDUCTASE;
ANIMAL;
CLINICAL TRIAL;
GENETICS;
HUMAN;
NEOPLASM;
ONCOGENE RAS;
REVIEW;
TUMOR SUPPRESSOR GENE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
CYCLIC AMP-DEPENDENT PROTEIN KINASES;
DNA MODIFICATION METHYLASES;
GENES, P53;
GENES, RAS;
HUMANS;
NEOPLASMS;
OLIGONUCLEOTIDES, ANTISENSE;
PROTEIN KINASE C;
PROTEIN KINASE C-ALPHA;
PROTO-ONCOGENE PROTEINS C-BCL-2;
PROTO-ONCOGENE PROTEINS C-MYB;
PROTO-ONCOGENE PROTEINS C-RAF;
RIBONUCLEOTIDE REDUCTASES;
|
|
EID: 16544387105
PISSN: 15431894
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (107)
|
